<?xml version="1.0" encoding="UTF-8"?>
<p id="p0195">The active principle of 
 <italic>Embelia schimperi</italic>, embelin is shown to inhibit hepatitis C virus (HCV) serine protease activity (
 <xref rid="b0110" ref-type="bibr">Hussein et al., 2000</xref>). In this report, our 
 <italic>in vitro</italic> assessment has revealed the novel antiviral property of embelin against HBV. In molecular docking, embelin formed complex with HBV Pol through Trp3, Pro5, Lys32 and His160 with an estimated free energy −6.1 kcal/mol.
</p>
